AMANDA LYNBERG: Open Payments
NPI 1952139982 · SANTA CLARITA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,447 in 49 payments from 23 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,447
Food & beverage: $1,177Education: $270
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $171 |
| E.R. Squibb & Sons, L.L.C. | 7 | $148 |
| SOBI, INC | 3 | $136 |
| Incyte Corporation | 5 | $129 |
| Novartis Pharmaceuticals Corporation | 5 | $122 |
| AstraZeneca Pharmaceuticals LP | 4 | $97 |
| GENZYME CORPORATION | 2 | $83 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $73 |
| GlaxoSmithKline, LLC. | 2 | $65 |
| ABBVIE INC. | 2 | $56 |
Products named: JAKAFI, AYVAKIT, BLENREP, ICLUSIG, EPKINLY, SCEMBLIX, PLUVICTO, PYRUKYND.
Industry payments across CA — which companies pay providers there.
